Cargando…
Lipidic profiles of patients starting peritoneal dialysis suggest an increased cardiovascular risk beyond classical dyslipidemia biomarkers
Patients on peritoneal dialysis (PD) have an increased risk of cardiovascular disease (CVD) and an atherogenic lipid profile generated by exposure to high glucose dialysis solutions. In the general population, the reduction of classic lipids biomarkers is associated with improved clinical outcomes;...
Autores principales: | Lluesa, Julia Hernández, López-Romero, Luis Carlos, Monzó, José Jesús Broseta, Marugán, Marta Roca, Boyano, Iris Viejo, Rodríguez-Espinosa, Diana, Gómez-Bori, Aina, Orient, Amparo Soldevila, Such, Ramón Devesa, Perez, Pilar Sánchez, Jaras, Julio Hernández |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525574/ https://www.ncbi.nlm.nih.gov/pubmed/36180468 http://dx.doi.org/10.1038/s41598-022-20757-9 |
Ejemplares similares
-
Acquired perforating dermatosis in patients on peritoneal dialysis: a report of 3 cases
por: Viejo-Boyano, Iris, et al.
Publicado: (2023) -
Impact of Acetate versus Citrate Dialysates on Intermediary Metabolism—A Targeted Metabolomics Approach
por: Broseta, José Jesús, et al.
Publicado: (2022) -
The metabolomic differential plasma profile between dialysates. Pursuing to understand the mechanisms of citrate dialysate clinical benefits
por: Broseta, José Jesús, et al.
Publicado: (2022) -
The Role of Dyslipidemia in Atherogenesis in Peritoneal Dialysis Patients
por: Rebić, Damir, et al.
Publicado: (2023) -
Role of the Nephrologist in Non-Kidney Solid Organ Transplant (NKSOT)
por: Viejo-Boyano, Iris, et al.
Publicado: (2023)